Skip to Content

Clinical Trials
Patient Portal

Loading component...

Loading component...

Ph2 Study of Fruquintinib plus FOLFIRI as 2L Treatment for mCRC

Phase II Clinical Trial

A Phase II Study Investigating Fruquintinib plus FOLFIRI as Second-Line Treatment for Participants with Metastatic Colorectal Cancer (FRUITFUL)

Indication: Colon Cancer, Rectal Cancer

Trial Number: 07011576

Trial Status: Call Proj Mgr

Learn more about this clinical trial.

About Us
Specialities & Services
Request Appointment
Careers
Contact Us
Media Center
Cancer Support Services
Careopolis

Find a Provider
Find a Location
Clinical Trials
Patient Portal
Patient Forms
Patient Resources
Patient Rights & Privacy
Insurance Information

© 2026 Texas Oncology. All rights reserved.|Privacy Notice|Terms of Use